Selection of oral bioavailability enhancing formulations during drug discovery

References

• Lipinski CA. (2002). Poor aqueous solubility—an industry wide problem in drug discovery. Am Pharm Rev, 5: 82–5.
   Google Scholar
• Saxena V, Panicucci R, Joshi Y, Garad S. (2009). Developability assessment in pharmaceutical industry: An integrated group approach for selecting developable candidates. j Pharm Sci, 98:1962–1979.
   PubMed Web of Science ®Google Scholar
• Chemburkar SR, Bauer J, Deming K, Spiwek H, Patel K, Morris J, et al. (2000). Dealing with the impact of ritonavir polymorphs on the late stages of bulk drug process development. Org Process Res Dev, 4:413–17.
   Web of Science ®Google Scholar
• Miller JM, Collman BM, Greene LR, Grant DJ, Blackburn AC. (2005). Identifying the stable polymorph early in the drug discovery-development process. Pharm Dev Technol, 10:291–297.
   PubMed Web of Science ®Google Scholar
• Fakes MG, Vakkalagadda BJ, Qian F, Desikan S, Gandhi RB, Lai C et al. (2009). Enhancement of oral bioavailability of an HIV-attachment inhibitor by nanosizing and amorphous formulation approaches. Int j Pharm, 370:167–174.
   PubMed Web of Science ®Google Scholar
• Ganta S, Paxton JW, Baguley BC, Garg S. (2009). Formulation and pharmacokinetic evaluation of an asulacrine nanocrystalline suspension for intravenous delivery. Int j Pharm, 367:179–186.
   PubMed Web of Science ®Google Scholar
• Attama AA, Reichl S, Müller-Goymann CC. (2008). Diclofenac sodium delivery to the eye: In vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct. Int j Pharm, 355:307–313.
   PubMed Web of Science ®Google Scholar
• Sigfridsson K, Forssén S, Holländer P, Skantze U, de Verdier J. (2007). A formulation comparison, using a solution and different nanosuspensions of a poorly soluble compound. Eur j Pharm Biopharm, 67:540–547.
   PubMed Web of Science ®Google Scholar
• Ning X, Sun J, Han X, Wu Y, Yan Z, Han J et al. (2011). Strategies to improve dissolution and oral absorption of glimepiride tablets: Solid dispersion versus micronization techniques. Drug Dev Ind Pharm, 37:727–736.
   PubMed Web of Science ®Google Scholar
• Zhang ZL, Le Y, Wang JX, Chen JF. (2011). Preparation of stable micron-sized crystalline irbesartan particles for the enhancement of dissolution rate. Drug Dev Ind Pharm Posted Online on 6 May 2011:1–8.
   Google Scholar
• Chhabra G, Chuttani K, Mishra AK, Pathak K. (2011). Design and development of nanoemulsion drug delivery system of amlodipine besylate for improvement of oral bioavailability. Drug Dev Ind Pharm Posted Online on 14 May 2011:1–10
   Google Scholar
• Sigfridsson K, Lundqvist AJ, Strimfors M. (2011). Particle size reduction and pharmacokinetic evaluation of a poorly soluble acid and a poorly soluble base during early development. Drug Dev Ind Pharm, 37:243–251.
   PubMed Web of Science ®Google Scholar
• Sigfridsson K, Nordmark A, Theilig S, Lindahl A. (2011). A formulation comparison between micro- and nanosuspensions: The importance of particle size for absorption of a model compound, following repeated oral administration to rats during early development. Drug Dev Ind Pharm, 37:185–192.
   PubMed Web of Science ®Google Scholar
• Sigfridsson K, Lundqvist AJ, Strimfors M. (2009). Particle size reduction for improvement of oral absorption of the poorly soluble drug UG558 in rats during early development. Drug Dev Ind Pharm, 35:1479–1486.
   PubMed Web of Science ®Google Scholar
• Hickey MB, Peterson ML, Scoppettuolo LA, Morrisette SL, Vetter A, Guzmán H et al. (2007). Performance comparison of a co-crystal of carbamazepine with marketed product. Eur j Pharm Biopharm, 67:112–119.
   PubMed Web of Science ®Google Scholar
• Trask AV, Motherwell WD, Jones W. (2006). Physical stability enhancement of theophylline via cocrystallization. Int j Pharm, 320:114–123.
   PubMed Web of Science ®Google Scholar
• Morissette SL, Almarsson O, Peterson ML, Remenar JF, Read MJ, Lemmo AV et al. (2004). High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids. Adv Drug Deliv Rev, 56:275–300.
   PubMed Web of Science ®Google Scholar
• McNamara DP, Childs SL, Giordano J, Iarriccio A, Cassidy J, Shet MS et al. (2006). Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API. Pharm Res, 23:1888–1897.
   PubMed Web of Science ®Google Scholar
• Bak A, Gore A, Yanez E, Stanton M, Tufekcic S, Syed R et al. (2008). The co-crystal approach to improve the exposure of a water-insoluble compound: AMG 517 sorbic acid co-crystal characterization and pharmacokinetics. j Pharm Sci, 97:3942–3956.
   PubMed Web of Science ®Google Scholar
• Pouton CW. (2000). Lipid formulations for oral administration of drugs: Non-emulsifying, self-emulsifying and ‘self-microemulsifying’ drug delivery systems. Eur j Pharm Sci, 11 Suppl 2:S93–S98.
   PubMed Web of Science ®Google Scholar
• O’Driscoll CM. (2002). Lipid-based formulations for intestinal lymphatic delivery. Eur j Pharm Sci, 15:405–415.
   PubMed Web of Science ®Google Scholar
• Porter CJ, Trevaskis NL, Charman WN. (2007). Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov, 6:231–248.
   PubMed Web of Science ®Google Scholar
• Wu Z, Guo D, Deng L, Zhang Y, Yang Q, Chen J. (2011). Preparation and evaluation of a self-emulsifying drug delivery system of etoposide-phospholipid complex. Drug Dev Ind Pharm, 37:103–112.
   PubMed Web of Science ®Google Scholar
• Wu X, Xu J, Huang X, Wen C. (2011). Self-microemulsifying drug delivery system improves curcumin dissolution and bioavailability. Drug Dev Ind Pharm, 37:15–23.
   PubMed Web of Science ®Google Scholar
• Shao B, Tang J, Ji H, Liu H, Liu Y, Zhu D et al. (2010). Enhanced oral bioavailability of Wurenchun (Fructus Schisandrae Chinensis extracts) by self-emulsifying drug delivery systems. Drug Dev Ind Pharm, 36:1356–1363.
   PubMed Web of Science ®Google Scholar
• Sakai K, Yoshimori T, Obata K, Maeda H. (2010). Design of self-microemulsifying drug delivery systems using a high-throughput formulation screening system. Drug Dev Ind Pharm, 36:1245–1252.
   PubMed Web of Science ®Google Scholar
• Attivi D, Ajana I, Astier A, Demoré B, Gibaud S. (2010). Development of microemulsion of mitotane for improvement of oral bioavailability. Drug Dev Ind Pharm, 36:421–427.
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhang GG, Neilly J, Marsh K, Mawhinney D, Sanzgiri YD. (2004). Enhancing the bioavailability of ABT-963 using solid dispersion containing Pluronic F-68. Int j Pharm, 286:69–80.
   PubMed Web of Science ®Google Scholar
• Joshi HN, Tejwani RW, Davidovich M, Sahasrabudhe VP, Jemal M, Bathala MS et al. (2004). Bioavailability enhancement of a poorly water-soluble drug by solid dispersion in polyethylene glycol-polysorbate 80 mixture. Int j Pharm, 269:251–258.
   PubMed Web of Science ®Google Scholar
• Sugimoto M, Okagaki T, Narisawa S, Koida Y, Nakajima K. (1998). Improvement of dissolution characteristics and bioavailability of poorly water-soluble drugs by novel cogrinding method using water soluble polymer. Int J Pharm, 160:11–19.
   Web of Science ®Google Scholar
• Konno H, Handa T, Alonzo DE, Taylor LS. (2008). Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine. Eur j Pharm Biopharm, 70:493–499.
   PubMed Web of Science ®Google Scholar
• Miller DA, DiNunzio JC, Yang W, McGinity JW, Williams RO 3rd. (2008). Targeted intestinal delivery of supersaturated itraconazole for improved oral absorption. Pharm Res, 25:1450–1459.
   PubMed Web of Science ®Google Scholar
• Vogt M, Kunath K, Dressman JB. (2008). Dissolution improvement of four poorly water soluble drugs by cogrinding with commonly used excipients. Eur j Pharm Biopharm, 68:330–337.
   PubMed Web of Science ®Google Scholar
• DiNunzio JC, Miller DA, Yang W, McGinity JW, Williams RO 3rd. (2008). Amorphous compositions using concentration enhancing polymers for improved bioavailability of itraconazole. Mol Pharm, 5:968–980.
   PubMed Web of Science ®Google Scholar
• Ranzani LS, Font J, Galimany F, Santanach A, Gomez-Gomar AM, Casadevall G et al. (2011). Enhanced in vivo absorption of CB-1 antagonist in rats via solid solutions prepared by hot-melt extrusion. Drug Dev Ind Pharm, 37:694–701.
   PubMed Web of Science ®Google Scholar
• Palanisamy M, Khanam J. (2011). Solid dispersion of prednisolone: Solid state characterization and improvement of dissolution profile. Drug Dev Ind Pharm, 37:373–386.
   PubMed Web of Science ®Google Scholar
• Jijun F, Lishuang X, Xiaoli W, Shu Z, Xiaoguang T, Xingna Z et al. (2011). Nimodipine (NM) tablets with high dissolution containing NM solid dispersions prepared by hot melt extrusion. Drug Dev Ind Pharm Posted Online 21 Mar 2011:1–11.
   Google Scholar
• DiNunzio JC, Hughey JR, Brough C, Miller DA, Williams RO 3rd., McGinity JW. (2010). Production of advanced solid dispersions for enhanced bioavailability of itraconazole using KinetiSol Dispersing. Drug Dev Ind Pharm, 36:1064–1078.
   PubMed Web of Science ®Google Scholar
• Shanbhag A, Rabel S, Nauka E, Casadevall G, Shivanand P, Eichenbaum G et al. (2008). Method for screening of solid dispersion formulations of low-solubility compounds–miniaturization and automation of solvent casting and dissolution testing. Int j Pharm, 351:209–218.
   PubMed Web of Science ®Google Scholar